Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/1/2026

Guideline for Ascites Evaluation Using SAAG and Ascitic Fluid Protein

1. Classification Framework (AASLD)

  • The serum‑ascites albumin gradient (SAAG) separates ascites due to portal hypertension (SAAG ≥ 1.1 g/dL) from non‑portal‑hypertension causes (SAAG < 1.1 g/dL); ascitic fluid total protein adds diagnostic nuance, especially for cardiac ascites. [1][2]

  • SAAG is calculated by subtracting the ascitic fluid albumin concentration from the simultaneously obtained serum albumin concentration. [1][3]

2. High‑Gradient Ascites (SAAG ≥ 1.1 g/dL) – Portal Hypertension (AASLD)

  • A SAAG ≥ 1.1 g/dL identifies portal‑hypertension‑related ascites with ≈ 97 % diagnostic accuracy. [1][2]4

  • Cirrhosis – the most common etiology, accounting for > 85 % of ascites cases in Western populations. (Strong epidemiologic data) 5

  • Massive hepatic metastases – can produce a high‑gradient ascites. [1][2]4

  • Right‑sided heart failure with hepatic congestion – yields a high‑gradient ascites. [1][2]4

  • Budd‑Chiari syndrome – also presents with SAAG ≥ 1.1 g/dL. 1

3. Low‑Gradient Ascites (SAAG < 1.1 g/dL) – Non‑Portal Causes (AASLD)

  • A SAAG < 1.1 g/dL excludes portal hypertension and prompts evaluation for:

    • Peritoneal carcinomatosis. [1][2]4
    • Tuberculous peritonitis. [1][2]4
    • Other non‑portal‑hypertension conditions (e.g., pancreatic disease, nephrotic syndrome). [1][2]4

4. Total Protein Interpretation (AGA)

  • High‑protein ascites (> 2.5 g/dL) – when combined with a high SAAG, strongly suggests cardiac ascites, distinguishing it from cirrhotic ascites which usually has lower protein. [5][1]

  • Low‑protein ascites (< 2.5 g/dL) – typical of cirrhotic ascites and guides decisions about primary prophylaxis for spontaneous bacterial peritonitis (SBP); protein measurement is recommended when SBP prophylaxis is being considered. (Evidence level: guideline recommendation) [1][2]4

5. Diagnostic Work‑up for New‑Onset Ascites (AASLD/AGA)

Step Recommendation Evidence
SAAG calculation Mandatory for all first episodes (inpatient & outpatient). Strong recommendation (based on multiple guideline sources). [1][2][3]
Cell count with differential Mandatory in all settings to detect SBP. Strong recommendation. [1][2][3]
Total protein concentration Mandatory for first episodes to aid etiologic classification. Strong recommendation. [1][2][3]
Gram stain & culture Mandatory for inpatients; bedside inoculation into blood‑culture bottles recommended. Strong recommendation. [5][1]

6. Management of Recurrent Ascites in Hospitalized Patients (AASLD)

  • SAAG – not required once the underlying cause is already established. [1][2]
  • Cell count – remains mandatory to monitor for SBP. [1][2]
  • Protein concentration – measured only when contemplating SBP prophylaxis. [1][2]

7. Clinical Pearls (AGA/AASLD)

  • Cardiac ascites differentiation – The older exudate‑transudate classification mislabels cardiac ascites as an “exudate” because of high protein; SAAG correctly categorizes it as portal‑hypertension‑related (SAAG ≥ 1.1 g/dL) while the high protein (> 2.5 g/dL) points to a cardiac etiology. [5][1]

  • Timing of paracentesis – In patients with cirrhosis and ascites, performing diagnostic paracentesis within 12–24 hours of hospital admission is associated with lower in‑hospital mortality. (Guideline‑level recommendation) 5

  • Selective additional testing – Cytology, amylase, and mycobacterial studies should be ordered only when SAAG results or clinical features raise suspicion for non‑portal‑hypertension causes. (Guideline‑level recommendation) [5][1]